2-Phenyltetrahydro-2H-pyran-4-ol
|
- $505.22 - $4220
- Product name: 2-Phenyltetrahydro-2H-pyran-4-ol
- CAS: 82065-19-8
- MF: C11H14O2
- MW: 178.23
- EINECS:
- MDL Number:MFCD12025409
- Synonyms:2-Phenyltetrahydro-2H-pyran-4-ol;cis-2-Phenyltetrahydro-2H-pyran-4-ol;(2R,4S)-2-phenyloxan-4-ol;2-phenyl-4-oxanol;2H-Pyran-4-ol,tetrahydro-2-phenyl-, (2R,4S)-rel-;rel-(2R,4S)-Tetrahydro-2-phenyl-2H-pyran-4-ol
4 prices
Selected condition：
Brand
- AK Scientific
- American Custom Chemicals Corporation
Package
- 5MG
- 250mg
- 1g
- 10g
- ManufacturerAK Scientific
- Product number2699AC
- Product description2-Phenyltetrahydro-2H-pyran-4-ol
- Packaging250mg
- Price$519
- Updated2021-12-16
- Buy
- ManufacturerAK Scientific
- Product number2699AC
- Product description2-Phenyltetrahydro-2H-pyran-4-ol
- Packaging1g
- Price$1081
- Updated2021-12-16
- Buy
- ManufacturerAK Scientific
- Product number2699AC
- Product description2-Phenyltetrahydro-2H-pyran-4-ol
- Packaging10g
- Price$4220
- Updated2021-12-16
- Buy
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberCHM0388587
- Product description2-PHENYLTETRAHYDRO-2H-PYRAN-4-OL 95.00%
- Packaging5MG
- Price$505.22
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| AK Scientific | 2699AC | 2-Phenyltetrahydro-2H-pyran-4-ol | 250mg | $519 | 2021-12-16 | Buy |
| AK Scientific | 2699AC | 2-Phenyltetrahydro-2H-pyran-4-ol | 1g | $1081 | 2021-12-16 | Buy |
| AK Scientific | 2699AC | 2-Phenyltetrahydro-2H-pyran-4-ol | 10g | $4220 | 2021-12-16 | Buy |
| American Custom Chemicals Corporation | CHM0388587 | 2-PHENYLTETRAHYDRO-2H-PYRAN-4-OL 95.00% | 5MG | $505.22 | 2021-12-16 | Buy |
Properties
Boiling point :329.3±42.0 °C(Predicted)
Density :1.123±0.06 g/cm3(Predicted)
pka :14.46±0.40(Predicted)
Density :1.123±0.06 g/cm3(Predicted)
pka :14.46±0.40(Predicted)
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|